(Hypertension. 1997;30:777-781.)
© 1997 American Heart Association, Inc.
Articles |
From the Divisions of Cardiology of the University of Massachusetts Medical Center (D.B.S., G.P.A.), Worcester, and Georgetown University Hospital (J.S.G.), Washington, DC, and the Cooperative Studies Program, Department of Veterans Affairs (D.W.W., D.J.R., B.J.M.).
Correspondence to Gerard P. Aurigemma, MD, University of Massachusetts Medical Center, 55 Lake Ave North, Worcester, MA 01655. E-mail gerard.aurigemma{at}banyan.ummed.edu
| Abstract |
|---|
|
|
|---|
0.45 and normal left ventricular
[LV] mass index) may have poor outcomes. It is unclear whether
systolic function abnormalities, shown to be present in
some patients with concentric LV hypertrophy (increased LV
mass index and relative wall thickness
0.45), are also present in
patients with concentric remodeling. To assess LV pump, chamber, and
myocardial function in hypertensive men with concentric remodeling,
clinical and echocardiographic data of 118 hypertensive
men with concentric remodeling were compared with data from 104
hypertensive men with normal relative wall thickness and normal LV mass
index. Chamber function was assessed by relating endocardial fractional
shortening to end-systolic circumferential stress, myocardial
function was assessed by relating midwall fractional shortening to
circumferential stress, and pump performance was assessed by
stroke volume (Teichholz method). Compared with hypertensive men with
normal relative wall thickness, concentric-remodeling patients had
lower stroke volume (84±20 versus 111±20 mL, P<.001).
Endocardial shortening was no different between the two groups (38±7%
versus 40±7%, P=NS), but midwall shortening was lower in
patients with concentric remodeling (20±3% versus 22±3%,
P<.001), despite lower end-systolic stress (81±25
versus 117±37 g/cm2, P<.001). Endocardial and
midwall stress-shortening regression plots classified 28% and 42%,
respectively, of the concentric remodeling patients below the fifth
percentile of hypertensive patients with normal geometry. These data
indicate that indexes of chamber and myocardial function are lower than
those observed in hypertensive patients with normal geometry. Thus,
indices of chamber, myocardial, and pump performance indicate
potential abnormalities in systolic function in men with
concentric remodeling.
Key Words: hypertrophy systolic function left ventricular mass
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
To investigate the association between LV geometry and systolic
function, the study population was classified by RWT,17
with a partition value of 0.45.13 Group 1 (n=118), which
had concentric remodeling, had RWT
0.45; group 2 (n=104) had normal
LV geometry (RWT <0.45) and served as the reference population.
Echocardiography
Details of the methodology used for obtaining
echocardiographic measurements in this patient
population have been previously published.15 Briefly,
standard American Society of Echocardiography (ASE)
measurement criteria19 were used. LV mass was calculated
by both the ASE criteria19 20 and the Cornell-Penn
convention.17 In view of the high prevalence of obesity in
the study population,15 it was decided that the most
appropriate means for LV mass indexation was LV
mass/height2.7.16 We used the partition value
of 51 g/m2.7 as a cutoff for LV
hypertrophy16 and excluded any patient with a
LV mass index equal to or exceeding this value. RWT of the LV was
expressed as the ratio of twice the posterior wall thickness to the
end-diastolic cavity dimension.18 LV volumes
were derived from M-mode data by the Teichholz
formula.21
LV Wall Stress
End-systolic circumferential wall stress (
c) was
calculated according to the following formula:
![]() |
LV Pump, Chamber, and Myocardial Function
Pump function was defined by stroke volume and was expressed as
the difference between end-diastolic and
end-systolic volumes.
Chamber function was assessed as percent FS at the endocardium, calculated as the difference between the end-diastolic and end-systolic circumference multiplied by 100. Myocardial function was assessed by percent circumferential FS at the midwall and was calculated using a two-shell cylindrical model, which does not require the conventional assumption that inner- and outer-wall thickening fractions are equal.10 11 Data provided by this method reflect shortening of a theoretical circumferential midwall fiber; in contrast to endocardial FS, midwall FS is not influenced by relative wall thickness.12 The formulas needed to calculate midwall FS are shown in "Appendix 1."
Endocardial and midwall FS were related to circumferential end-systolic wall stress by use of linear regression so that LV chamber and myocardial function, respectively, could be assessed. The relation of FS to end-systolic stress has been postulated to be a relatively afterload-independent index of contractile state.24 25
Obesity
To investigate the interaction between obesity and geometry,
body mass (Quetelet) index, a measure of adiposity,26 27
was calculated as weight (kg) divided by height (m) squared. Normal
weight was defined by body mass index <27 kg/m2,
overweight as 27 to 30 kg/m2, and obesity as >30
kg/m2.15
Statistical Analysis
Data are expressed as mean±SD. Comparisons of continuous
variables between the concentric remodeling and normal geometry
groups were performed by Student's t test for independent
groups.
A two-way ANOVA with interaction was used to address the relation between midwall and endocardium shortening indexes (dependent variables) and RWT, Quetelet index, and their interaction (independent variables). Regression coefficients of endocardial and midwall FS versus circumferential end-systolic stress were obtained for patients with concentric remodeling and those with normal RWT. Ninety-five percent confidence intervals were then established for subjects with normal geometry, who were used as a reference population. Subjects with concentric remodeling and values for LV functional parameters below the fifth percentile of the reference population were considered to have depressed chamber and myocardial function relative to hypertensive patients with normal geometry.
A value of P<.05 was considered to be statistically significant. All tests were two-sided.
| Results |
|---|
|
|
|---|
|
Echocardiographic Data
The principal echocardiographic data are displayed
in Table 2
. Group 1 patients had smaller
LV diastolic and systolic cavity dimensions and
larger septal and posterior wall thickness than group 2 patients. LV
mass index, by both ASE and Cornell-Penn conventions, did not differ
between the two groups.
|
Systolic Function
There was no difference in the endocardial FS between the two
groups (P=.09). By contrast, midwall FS was significantly
lower in group 1 than in group 2 (P<.001), despite
decreased afterload; end-systolic circumferential stress for
group 1 was lower than that for group 2 (P<.0001),
suggesting that myocardial function in group 1 patients is reduced as
compared with hypertensive control patients with normal geometry. Pump
function, as determined by stroke volume, was also reduced in group 1
compared with group 2 (P<.001).
Stress-shortening relations at the endocardium and midwall (Figs 1
and 2
) were examined to analyze chamber and myocardial functions,
respectively. Endocardial FS was inversely related to circumferential
end-systolic stress both in individuals with normal geometry
(r=-.90, P=.0001) and in patients with
concentric remodeling (r=-.89, P<.0001).
Similarly, the inverse relation of midwall fractional shortening to
end-systolic stress was significant in both subjects with
normal RWT (r=-.76, P=.0001) and in subjects
with concentric remodeling (r=-.44, P=.0001).
Stress-shortening relation values are summarized in Table 3
.
|
|
|
Relative to the control population, 28% of patients with concentric
remodeling (Fig 1
) had
chamber function determined by endocardial stress-shortening relation
below the fifth percentile. Likewise, 42% of patients with concentric
remodeling had midwall stress-shortening coordinates below the fifth
percentile.
Relation Between Obesity, Hypertension, LV Geometry, and
Midwall Shortening
On a two-way ANOVA with interaction, the relation between
RWT and midwall FS was the same across all three levels of the Quetelet
index. Adjustment for systolic blood pressure did not change
this relation. Thus, there did not appear to be a significant influence
of obesity on myocardial function as determined by midwall
shortening.
| Discussion |
|---|
|
|
|---|
Our midwall-shortening data qualitatively agree with those of de Simone et al,6 who studied 50 patients with concentric remodeling and found that midwall FS was reduced compared with normotensive control patients (15±2% versus 17±2%, P<.01). However, our chamber function data (endocardial FS) differ from those of de Simone et al; whereas the mean value for endocardial FS in our study was not different in patients with concentric remodeling compared with hypertensive patients with normal LV mass and RWT (38% versus 40%, P=.10), when endocardial FS was plotted against end-systolic stress, 28% of the patients fell below the fifth percentile, suggesting depressed chamber function in those individuals. This finding of depressed chamber function differs from that of de Simone et al,6 who reported a normal observed-to-predicted endocardial stress-shortening relation in hypertensive patients with concentric remodeling compared with normotensive control patients. It is likely that our results differ from those of de Simone et al6 because our reference population comprised hypertensive patients with normal LV RWT, whereas de Simone et al's reference population comprised normotensive individuals with normal LV structure. It has been argued that hypertensive patients with normal LV mass and normal RWT have "enhanced" endocardial shortening for the level of afterload.28 29 30 Therefore, relative to these individuals, concentric-remodeling patients may appear to have reduced endocardial shortening. Support for this conclusion may be found in the data recently reported by Verdecchia et al,4 who compared hypertensive patients with concentric remodeling to hypertensive patients with normal RWT and found a lower observed-to-predicted endocardial FS (101% versus 110%, P<.01) in the concentric remodeling group. Concentric remodeling subjects and hypertensive subjects with normal RWT in the series of Verdecchia et al had similar endocardial FS, despite 20% lower values for meridional end-systolic wall stress (57 versus 71 g/cm2, P<.01) in the concentric remodeling group.4 It is also possible that subjects who fall below the confidence limits of the endocardial stress-shortening relation actually have an abnormality in LV chamber performance. Unfortunately, the lack of a normotensive control group does not permit us to fully evaluate this intriguing possibility.
In a recent study involving a small number of older hypertensive individuals with concentric LV geometry,7 we found that approximately one third of patients with normal ejection fraction but abnormal RWT have a substantial abnormality in systolic pump performance that is characterized by low stroke volume and low cardiac output. The present study extends that observation to a much larger group of patients with high relative wall thickness and normal LV mass index. Thus, the smaller stroke volume associated with high RWT observed in the present study is likely to be related to chamber size, suggesting that concentric geometry develops at the expense of a smaller cavity volume.
Obesity
Obesity is an independent predictor of LVH in patients with
mild to moderate hypertension.15 Furthermore, the effects
of systolic blood pressure on LV mass are amplified by
obesity.15 There are conflicting data, however, concerning
the relation among LV geometry, hypertrophy patterns, and
obesity.15 31 32 33 Data from the Veterans Affairs
Cooperative Study show that concentric LVH is highly prevalent in obese
patients.15 In contrast, de Simone et al reported that
eccentric hypertrophy was the most common pattern in obese
patients and that concentric remodeling was less prevalent among obese
patients than among normal-weight subjects.33 There were
several reasons for investigating the relation of obesity to
systolic function in our study population. We wanted to
determine whether there were subtle indications of reduced
systolic function in obese subjects because midwall mechanics
may be abnormal when ejection fraction is normal and RWT is high.
Because indexing LV mass to body surface area in a population with a
high prevalence of obesity might misclassify some obese subjects with
concentric LVH as having concentric remodeling, we chose, as our
indexation method, LV mass/height2.7. In addition, we also
analyzed our data by the Quetelet index to determine whether
reduced myocardial function is related to geometry or
hypertrophy. Our results show that in this population,
reduced midwall shortening (relative to hypertensive patients with
normal geometry) is independent of obesity because the interaction
between midwall shortening, RWT, and systolic blood pressure
was the same for all levels of body mass index.
Clinical Implications
Koren et al2 were the first to report that
patients with the concentric remodeling pattern suffered higher
mortality than subjects matched for LV mass and blood pressure. These
findings were confirmed recently by Verdecchia et al,4 who
studied a larger series of subjects with essential hypertension and
reported that concentric remodeling was associated with an increased
rate of cardiovascular morbid events compared with
patients with normal RWT (RR, 2.56; 95% CI, 1.20 to 5.45;
P<.01). In contrast, Krumholz et al,5
reporting on the Framingham Heart Study population, found that geometry
was not an independent predictor of cardiovascular
events after adjustment for LV mass, although there was a trend toward
more events in men. The study population in the report by Krumholz et
al5 differed from the previously mentioned
studies2 4 in hypertension status and racial composition.
It is interesting to note that the Framingham Heart Study subjects were
less likely to be black and that blacks have a higher prevalence of
concentric geometry.34 It is also important to point out
that the study by Krumholz et al5 was a general population
study. In contrast, the study populations of Koren et al2
and Verdecchia et al4 comprised referred hypertensive
subjects who were judged to be free of heart disease. It is not certain
how the findings reported here relate to prognosis. A recent study by
de Simone et al35 suggests that reduced midwall shortening
is, like LVH, an independent predictor of
cardiovascular events. It is possible, therefore, that
the subjects with reduced midwall FS represent a group at high
risk for cardiac morbid events. It is also possible that the
development of concentric geometry may indicate an early stage of
transition to overt systolic dysfunction as seen in animal
models of pressure-overload hypertrophy.36 To
that extent, the development of concentric geometry may serve to
maintain normal pump performance despite depressed myocardial
function.7 37
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Appendix 1 |
|---|
|
|
|---|
2. End-systolic epicardial radius (b)=(Ds/2)+PW SYS or (Ds/2)+hes, where hes is PW SYS and Ds is LV dimension SYS.
3. End-systolic midwall "increment"= a'=-{Ds-square root (Ds2 +[hes(2 · Dd+hd)(Ds+hes)]/(Dd+hd)}/2
where hd is posterior wall DIAS, Ds is LV dimension SYS, hes is PW SYS, and Dd is LV dimension DIAS.
4. End systolic midwall radius (r)=a+a'.
5. Midwall fractional shortening (%)=[(Dd+hd)(Ds+2 · a')]/[Dd+hd] · 100.
Received October 23, 1996; first decision November 14, 1996; accepted March 6, 1997.
| References |
|---|
|
|
|---|
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.[Abstract]
4. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G, Porcellati C. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995;25:871-878.[Abstract]
5. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995;25:879-884.[Abstract]
6. De Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH. Assessment of left ventricular function by the midwall fractional shortening/end systolic stress relation in human hypertension. J Am Coll Cardiol. 1994;23:1444-1451.[Abstract]
7. Aurigemma GP, Gaasch WH, McLaughlin M, McGinn R, Sweeney A, Meyer TE. Reduced systolic pump performance and depressed myocardial contractile function in patients with normal ejection fraction and a high relative wall thickness. Am J Cardiol. 1995;76:702-705.[Medline] [Order article via Infotrieve]
8.
Palmon L, Reichek N, Yeon S, Clark N, Brownson D,
Hoffman E, Axel L. Intramural myocardial shortening in
hypertensive left ventricular hypertrophy with
normal pump function. Circulation. 1994;89:122-131.
9. Jones C, Raposo G, Gibson D. Functional importance of the long axis dynamics of the human left ventricle. Br Heart J. 1990;65:215-220.
10.
Shimizu G, Zile MR, Blaustein AS, Gaasch WH.
Left ventricular chamber filling and midwall fiber
lengthening in patients with left ventricular
hypertrophy: overestimation of fiber velocities by
conventional midwall measurements. Circulation. 1985;71:266-272.
11.
Shimizu G, Hirota Y, Kawamura K, Yoshio K, Saito T,
Gaasch WH. Left ventricular midwall mechanics in
systemic arterial hypertension: myocardial function is
depressed in pressure-overload hypertrophy.
Circulation. 1991;83:1676-1684.
12. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195-202.[Abstract]
13. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering T, Sergio P, Vargiu P, Simongine I, Laragh J. Patterns of LV hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-1560.[Abstract]
14.
Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED,
Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener JS.
Single drug therapy for hypertension in men: a comparison of six
antihypertensive agents with placebo. N Engl J
Med. 1993;328:914-921.
15. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, Williams DW, Henderson WG. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol. 1994;24:1492-1498.[Abstract]
16. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056-1062.[Abstract]
17. Devereux RB, Lutas EM, Casale PN, Kliegfield P, Eisenberg RR, Hammond IW, Miller D, Reis G, Alderman MH, Laragh JH. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.[Medline] [Order article via Infotrieve]
18. Savage DD, Garrison RJ, Kannel WB. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham study. Circulation. 1987;75(suppl I):I-26-I-33.
19.
Sahn DJ, De Maria AN, Kisslo J, Weyman A.
Recommendations regarding quantitation in M-mode
echocardiography: results of a survey of
echocardiographic measurements.
Circulation. 1978;58:1072-1083.
20.
Troy BL, Pombo J, Rackley CE. Measurement of
left ventricular wall thickness and mass by
echocardiography. Circulation. 1972;45:602-611.
21. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence and absence of asynergy. Am J Cardiol. 1976;37:7-11.[Medline] [Order article via Infotrieve]
22.
Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein
AS. Stress-shortening relations and myocardial blood flow in
compensated and failing canine hearts with pressure-overload
hypertrophy. Circulation. 1989;79:872-883.
23.
Rozich JD, Carabello BA, Usher BW, Kratz JM, Bell AE,
Zile MR. Mitral valve replacement with and without chordal
preservation in patients with chronic mitral
regurgitation: mechanisms for differences in
postoperative ejection performance.
Circulation. 1992;86:1718-1726.
24.
Reichek N, Wilson J, St John Sutton M, Plappert T,
Goldberg S, Hirshfield J. Noninvasive determination of left
ventricular end-systolic stress: validation of the
method and initial application. Circulation. 1982;65:99-108.
25.
Grossman W, Braunwald E, Mann T, McLaurin LP, Green
LH. Contractile state of the left ventricle in man as estimated
from end-systolic pressure-volume relations.
Circulation. 1977;55:613-618.
26. Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK, Malina R. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes. 1986;10:493-502.[Medline] [Order article via Infotrieve]
27. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985;103:983-988.
28.
Lutas EM, Devereux RB, Reis G, Alderman MH, Pickering
TG, Borer JS, Laragh JH. Increased cardiac performance
in mild essential hypertension: left ventricular
mechanics. Hypertension. 1985;7:979-988.
29.
de Simone G, Di Lorenzo L, Costantino G, Moccia D,
Buonissimo S, De Divitiis O. Supernormal
contractility in primary hypertension without left
ventricular hypertrophy.
Hypertension. 1988;11:457-463.
30.
Hartford MM, Wikstrand JC, Wallentin I, Ljungma
SM, Berglund G. Left ventricular wall stress and
systolic function in untreated primary hypertension.
Hypertension. 1985;7:97-104.
31. Lauer MS, Anderson KM, Kannel WB, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol. 1992;19:130-134.[Abstract]
32.
Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack
JM, Cutler JA, Grimm R, Stamler J.
Echocardiographic correlates of left
ventricular structure among 844 mildly hypertensive men and
women in the Treatment of Mild Hypertension Study (TOMHS).
Circulation. 1993;87:476-486.
33.
de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh
JH. Relation of obesity and gender to left
ventricular hypertrophy in normotensive and
hypertensive adults. Hypertension. 1994;23:600-606.
34. Koren MJ, Mensah GA, Blake J, Laragh JH, Devereux RB. Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. Am J Hypertens. 1993;6:815-823.[Medline] [Order article via Infotrieve]
35.
de Simone G, Devereux R, Koren MJ, Casale PN, Laragh
JH. Midwall left ventricular mechanics: an
independent predictor of cardiovascular risk in
arterial hypertension. Circulation. 1996;93:259-265.
36.
Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma
GP, Douglas PS. Serial
echocardiographic-Doppler assessment of left
ventricular geometry and function in rats with pressure
overload hypertrophy: chronic angiotensin
converting enzyme inhibition attenuates the transition to heart
failure. Circulation. 1995;91:2642-2654.
37.
Rademakers FE, Rogers WJ, Guier WH, Hutchins GM, Siu
CO, Weisfeldt ML, Weiss JL, Shapiro EP. Relation of regional
cross-fiber shortening to wall thickening in the intact heart:
three-dimensional strain analysis by NMR tagging.
Circulation. 1994;89:1174-1182.
This article has been cited by other articles:
![]() |
A. Narayanan, G. P. Aurigemma, M. Chinali, J. C. Hill, T. E. Meyer, and D. A. Tighe Cardiac Mechanics in Mild Hypertensive Heart Disease: A Speckle-Strain Imaging Study Circ Cardiovasc Imaging, September 1, 2009; 2(5): 382 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baltabaeva, M. Marciniak, B. Bijnens, J. Moggridge, F. J. He, T. F. Antonios, G. A. MacGregor, and G. R. Sutherland Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension Eur J Echocardiogr, July 1, 2008; 9(4): 501 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hill and E. N. Olson Cardiac Plasticity N. Engl. J. Med., March 27, 2008; 358(13): 1370 - 1380. [Full Text] [PDF] |
||||
![]() |
A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Aurigemma, M. R. Zile, and W. H. Gaasch Contractile Behavior of the Left Ventricle in Diastolic Heart Failure: With Emphasis on Regional Systolic Function Circulation, January 17, 2006; 113(2): 296 - 304. [Full Text] [PDF] |
||||
![]() |
B. D. Rosen, T. Edvardsen, S. Lai, E. Castillo, L. Pan, M. Jerosch-Herold, S. Sinha, R. Kronmal, D. Arnett, J. R. Crouse III, et al. Left Ventricular Concentric Remodeling Is Associated With Decreased Global and Regional Systolic Function: The Multi-Ethnic Study of Atherosclerosis Circulation, August 16, 2005; 112(7): 984 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Berenji, M. H. Drazner, B. A. Rothermel, and J. A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H8 - H16. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rinder, R. J. Spina, L. R. Peterson, C. J. Koenig, C. R. Florence, and A. A. Ehsani Comparison of effects of exercise and diuretic on left ventricular geometry, mass, and insulin resistance in older hypertensive adults Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R360 - R368. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Peterson, M. R. Rinder, K. B. Schechtman, R. J. Spina, K. L. Glover, D. T. Villareal, and A. A. Ehsani Peak exercise stroke volume: associations with cardiac structure and diastolic function J Appl Physiol, March 1, 2003; 94(3): 1108 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yuda, V. Khoury, and T. H. Marwick Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1311 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mayet, B. Ariff, B. Wasan, N. Chapman, M. Shahi, N. R. Poulter, P. S. Sever, R. A. Foale, and S. A. McG. Thom Improvement in Midwall Myocardial Shortening With Regression of Left Ventricular Hypertrophy Hypertension, November 1, 2000; 36(5): 755 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Turner, R. J. Spina, W. M. Kohrt, and A. A. Ehsani Effect of Endurance Exercise Training on Left Ventricular Size and Remodeling in Older Adults With Hypertension J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2000; 55(4): 245M - 251. [Abstract] [Full Text] |
||||
![]() |
B. D. Rosen, T. Edvardsen, S. Lai, E. Castillo, L. Pan, M. Jerosch-Herold, S. Sinha, R. Kronmal, D. Arnett, J. R. Crouse III, et al. Left Ventricular Concentric Remodeling Is Associated With Decreased Global and Regional Systolic Function: The Multi-Ethnic Study of Atherosclerosis Circulation, August 16, 2005; 112(7): 984 - 991. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |